COMMUNIQUÉS West-GlobeNewswire

Quiet Communities and Science for Georgia Release First-of-its-Kind Study on the Impacts of Data Center and Cryptomining Noise
14/09/2026
New national survey documents widespread reports of persistent noise and disrupted quality of life as AI data centers and cryptomines rapidly expand across the United States LINCOLN, Mass. and ATLANTA, Sept. 14, 2026 ( [...]
KFSH Riyadh Records Zero High-Risk Findings Across Nearly 1,800 Measures in JCI Reaccreditation
14/09/2026
RIYADH, Saudi Arabia, Sept. 14, 2026 (GLOBE NEWSWIRE) -- King Faisal Specialist Hospital and Research Centre (KFSH) in Riyadh has secured reaccreditation as an Academic Medical Center from Joint Commission International [...]
GENFIT Advances Nangibotide in Phase 2 Clinical Investigation in ACLF
14/09/2026
GENFIT's acquisition of nangibotide, a differentiated late-stage asset, reinforces the Company’s portfolio of innovative therapies addressing high unmet medical needs The investigation in Phase 2 is supported by a [...]
GENFIT engage un programme de développement clinique de phase 2 avec Nangibotide dans l’ACLF
14/09/2026
L’acquisition par GENFIT du nangibotide, un candidat-médicament au profil différencié en phase avancée de développement clinique, renforce le portefeuille de thérapies innovantes de la Société adressant d’importants [...]
IPSEN - Buy-back programme - Art 5 of MAR - Week 37 - 2026
14/09/2026
Aggregated presentation by day and by market Weekly report on share repurchases from 7th September to 11th September 2026 Name of the Issuer Identify code of the Issuer Transaction day Identify code of the financial [...]
IPSEN - Achats effectués dans les conditions de l'Article 5 du Règlement MAR - Semaine 37 - 2026
14/09/2026
Présentation agrégée par jour et par marché Déclaration des transactions sur actions propres réalisées du 7 septembre au 11 septembre 2026 Nom de l'émetteur Code identifiant de l'émetteur (code LEI) Jour de la [...]
Paralyzed Marine Veteran Stands and Walks at Enjoy Illinois 300 as Patriot Mobile Puts SoldierStrong on Ty Dillon's No. 10
14/09/2026
STAMFORD, Conn., Sept. 14, 2026 (GLOBE NEWSWIRE) -- SoldierStrong, the national nonprofit committed to delivering revolutionary medical technologies to America's veterans, brought its mission to the NASCAR Cup Series [...]
Zealand Pharma - Transactions related to share buy-back program (week 37, 2026)
14/09/2026
Company announcement No. 48 / 2026 Zealand Pharma - Transactions related to share buy-back program (week 37, 2026) Copenhagen, Denmark, September 14, 2026 – Zealand Pharma A/S ("the Company" or “Zealand Pharma”) (Nasdaq [...]
Wellthy Acquires Cleo as Two Leaders Come Together to Create the Singular Platform for Family Care
14/09/2026
Wellthy's acquisition of Cleo brings together two leaders in family care, expanding support for employers, health plans, and families. NEW YORK, Sept. 14, 2026 (GLOBE NEWSWIRE) -- Wellthy today announced its acquisition [...]
PDS Biotech Announces Initial Closing of up to $22.3 Million PIPE Financing and the Appointment of Dr. Patrick Soon-Shiong to Its Board of Directors
14/09/2026
Gross Proceeds of $11.3 Million at Initial Closing Transaction Led by Dr. Patrick Soon-Shiong, Founder of NantWorks PRINCETON, N.J., Sept. 14, 2026 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (Nasdaq: PDSB) ("PDS [...]
Children’s National receives $56.25 million Pediatric Prevention Network award
14/09/2026
Washington, DC, Sept. 14, 2026 (GLOBE NEWSWIRE) -- Children’s National will receive $56.25 million over five years to help lead the Pediatric Prevention Network’s (PPN) work to strengthen pediatric disaster preparedness [...]
Biofrontera Announces FDA Approval of Ameluz® Red Light PDT for the Treatment of Superficial Basal Cell Carcinoma
14/09/2026
Ameluz used in conjunction with the RhodoLED lamp becomes the first and only photodynamic therapy approved in the United States to treat a skin cancer, creating an additional growth opportunity for Biofrontera’s [...]
Catalyst MedTech Helps Imaging Providers See What’s Next in Nuclear Cardiology at ASNC 2026
14/09/2026
Company to Showcase Expanded Digirad® Cardiac SPECT Portfolio, PET/CT Solutions, Windows 11 Modernization and Nationwide Imaging Service PITTSBURGH, Sept. 14, 2026 (GLOBE NEWSWIRE) -- Catalyst MedTech today announced it [...]
SafeSpace Global Announces First K-12 School Installation of Its AI-Powered Physical Safety Platform
14/09/2026
KNOXVILLE, Tenn., Sept. 14, 2026 (GLOBE NEWSWIRE) -- SafeSpace Global Corporation (OTCID: SSGC) (“SafeSpace Global” or the “Company”), a publicly traded, applied multimodal AI-powered physical safety and security [...]
Novo Nordisk A/S - share repurchase programme
14/09/2026
Bagsværd, Denmark, 14 September 2026 – On 6 May 2026, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No 596/2014 of the European Parliament and Council of 16 April 2014 ( [...]
Insiders Continue Buying, as NeOnc Moves NEO100 Toward Its Next Regulatory Test
14/09/2026
DENVER, Sept. 14, 2026 (GLOBE NEWSWIRE) -- (247marketnews.com) -- NeOnc Technologies Holdings (NASDAQ: NTHI) is sending investors a signal that is impossible to ignore. The company's CEO, President and director, Amir F [...]
Ernexa Therapeutics to Present at the H.C. Wainwright 28th Annual Global Investment Conference
14/09/2026
President and CEO Sanjeev Luther to present on Wednesday, September 16, 2026, at 12:00 p.m. ET Management available for one-on-one meetings with investors during the conference CAMBRIDGE, Mass., Sept. 14, 2026 (GLOBE [...]
Press Release: Sanofi and Cheplapharm to create new strategic partnership in mature medicines
14/09/2026
Sanofi and Cheplaphar m to create new strategic partnership i n mature medicines Paris , September 14, 2026 . Sanofi and Cheplapharm, a European leader in well-established medicines, today announced their intention to [...]
Communiqué de presse : Sanofi et Cheplapharm créent un nouveau partenariat stratégique autour des médicaments matures
14/09/2026
Sanofi et Cheplapharm créent un nouveau partenariat stratégique autour de s médicaments matures Paris, 14 septembre 2026. Sanofi et Cheplapharm, leader européen des médicaments matures, ont annoncé aujourd'hui leur [...]

Pages